| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |